Navigation Links
Robbins Arroyo LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Hemispherx Biopharma, Inc.
Date:1/17/2013

SAN DIEGO and PHILADELPHIA, Jan. 17, 2013 /PRNewswire/ -- Shareholder rights attorneys at Robbins Arroyo LLP announce that purchasers of Hemispherx Biopharma, Inc. (NYSE: HEB) ("Hemispherx" or the "Company") have filed a complaint in the U.S. District Court for the Eastern District of Pennsylvania. The complaint alleges the Company and certain of its officers and directors violated the Securities Exchange Act of 1934 between March 19, 2012 and December 17, 2012 (the "Class Period").  Hemispherx is a biopharmaceutical company that focuses on the development of new drug therapies to treat viral and immune based chronic disorders.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO)

The complaint alleges that the Company issued a series of materially false and misleading statements to investors regarding the safety and efficacy of Ampligen®, a drug intended as a treatment for Chronic Fatigue Syndrome.  Specifically, the complaint alleges that Hemispherx misrepresented and failed to disclose that Ampligen did not meet safety and efficacy requirements because its clinical trials were not properly designed.

Hemispherx submitted a New Drug Application to the U.S. Food and Drug Administration ("FDA") for Ampligen in 2007. In 2009, the FDA found that the Phase III study did not adequately support the approval of Ampligen. 

In a July 11, 2012 press release, Hemispherx announced that rather than conducting a new clinical trial, it reached an agreement with the FDA to submit post-hoc analysis of Ampligen for FDA consideration. However, in a meeting held in June 2012 between Hemispherx and FDA officials concerning Hemispherx's ability to gain ap
'/>"/>

SOURCE Robbins Arroyo LLP
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Robbins Umeda LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Abiomed, Inc.
2. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
3. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
4. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
5. Misonix Announces New Distribution Agreement For Panama
6. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
7. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
8. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
9. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
10. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
11. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... The Assistance Fund announces the addition of ... assistance for copay to individuals diagnosed with Melanoma. ... of the Melanoma Copay Assistance Program to our portfolio ... director. "With each additional program we are closer to ... no one is denied access to medications due to ...
(Date:5/22/2015)... , May 22, 2015  The U.S. Food ... (filgrastim-sndz) -- the first biosimilar product approved in ... points toward growth in the contract manufacturing organization ... CMO industry is geared to the production of ... major biopharmaceutical products. The healthcare market research publisher,s ...
(Date:5/22/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/28m7nx/guide_to_prepare ) has announced ... Application Dossiers for Oversea Medical device registration and ... to their offering. The Chinese medical ... the most growth potentiality, which is attracting more ... to penetrate such market. It is estimated that ...
Breaking Medicine Technology:The Assistance Fund Adds Melanoma Assistance Program 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 2China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 3
... JERUSALEM, Jan. 11 IDenta Corp. (PinkSheets: IDTA) announced today ... a General Screening Explosive Identifier. , This kit has been ... ampoules it contains, the following substances can be identified with ... Identifier.. , Ampoule 1: TNT, DNT, Tetryl. , Ampoule ...
... LAGUNA BEACH, California, January 11 Advanced ... announced today that it has completed a $5 million ,Series,B, ... venture,capital firm specialized in medical technology investments, and is expected,to ... was founded in 2007 to develop a novel irrigated radiofrequency,cardiac ...
Cached Medicine Technology:International Drug & Explosives Detection Firm IDenta Corp Announces that the TNT/PETN/RDX/NITRATE Test Kit can be used as a General Screening Explosive Identifier 2International Drug & Explosives Detection Firm IDenta Corp Announces that the TNT/PETN/RDX/NITRATE Test Kit can be used as a General Screening Explosive Identifier 3Advanced Cardiac Therapeutics Completes $5 Million Financing 2Advanced Cardiac Therapeutics Completes $5 Million Financing 3
(Date:5/26/2015)... (PRWEB) May 26, 2015 Learning ZoneXpress ... line, Nutrition Education Cards . These cards have ... engaging photography and simple, easy-to-read text, these new educational ... . They offer practical nutrition tips and suggestions to ... titles available are: , + MyPlate: Eat for a ...
(Date:5/26/2015)... 2015 Writers and editors can ... Vasont® CCMS to make creating, editing, and managing ... component content management system (CCMS) software provider, certified ... oXygen XML Editor Version 17.0, Syncro Soft’s latest ... extension merges key editorial functionality of the Vasont ...
(Date:5/26/2015)... Ore. (PRWEB) May 26, 2015 ... association which provides talent development to credit union CEOs, ... for their employees to boost the bottom line. CUES ... program that has helped dozens of credit unions across ... According to a 2014-2015 Staff Benefits Report ...
(Date:5/26/2015)... DENVER (May 26, 2015) – As ... is also experiencing many of the growing pains felt ... one major issue that cannabis companies now have to ... paper and plastic that marijuana growers, dispensaries and consumers ... we see the opportunity to enhance our environment for ...
(Date:5/26/2015)... General Networks Corporation today announced ... alliance ensures joint customers will benefit from the ... expertise in building enterprise content and process management ... customers integrate, manage and operationalize their data and ... “Our customers are seeking tools to make better ...
Breaking Medicine News(10 mins):Health News:Learning ZoneXpress Introduces New Educational Resource for WIC, SNAP-Ed, and EFNEP 2Health News:Vasont Systems Certifies the Integration between the Vasont® Component Content Management System and oXygen® XML Editor 17.0 2Health News:CUES Expects a Positive Return on Wellness with hubbub health™ 2Health News:CUES Expects a Positive Return on Wellness with hubbub health™ 3Health News:Colorado Cannabis Business Expands its Recycling Initiative, to Encourage Marijuana Retailers to Keep Their Businesses Green 2Health News:Colorado Cannabis Business Expands its Recycling Initiative, to Encourage Marijuana Retailers to Keep Their Businesses Green 3Health News:General Networks Corporation Announces Alliance with MarkLogic 2
... patients who undergo chemotherapy or radiation expect a high number ... chemotherapy or radiation can diminish the quality of life for ... as nausea, he or she is more likely to develop ... and the type of cancer influence how many side effects ...
... Patients with rheumatoid arthritis who receive a more intensive ... remission of their disease, finds a new study.// ... patients with similar levels of disease to one of ... drugs to fight rheumatoid arthritis, along with steroid injections. ...
... people in every 100,000. It is most common in people ... Simple exercises performed at home may help patients with vertigo ... ,Researchers studied 70 patients who had a form of vertigo ... Participants reported experiencing episodes of nausea or a feeling of ...
... the Centers for Disease Control and Prevention says 30 percent ... percentile,// and 15 percent of children have a BMI above ... years and the National Institutes of Health report that overweight ... keeps them at high risk for heart disease, diabetes, high ...
... can be done to activate the cells to destroy tumors. ... // cancer may be due to different cell priming or ... found a method to activate the anti-cancer cells in mice. ... patients and separated the anti-cancer cells. The cells were stimulated ...
... A new study shows soy protein with isoflavones does ... mineral density, or cholesterol in postmenopausal women.// ... menopause is related to a decrease in bone mineral ... cholesterol. Some women have taken hormone therapy to offset ...
Cached Medicine News:
Panoramic styling that contours closely to the face and brow. Saddle bridge fits average to fuller noses. Adjustable temple hinge adjusts up or down, longer or shorter. Soft cushion behind ear for co...
QualCraft™ Euro Lite has a molded nylon frame that fits most faces. Universal keyhole nose bridge fits narrow to average noses. Available with or without lead vinyl-lined side shields....
Qualcraft Radiation Readers, Carbon Glasses. Protect yourself and have close-vision clarity....
The Bronze Metalite Constructed of optical-grade steel with bronze electroplate. Fitted lead side shields that create a seal to the front of the lenses for increased scatter protection....
Medicine Products: